Trials / Terminated
TerminatedNCT00368641
Heart Failure and Peritoneal Ultrafiltration
Treatment-Resistant Heart Failure (HF) and Peritoneal Ultrafiltration (PUF): A Randomized Prospective Trial of Standard Care Versus Standard Care With Peritoneal Ultrafiltration in Patients With Treatment-Resistant Severe Heart Failure
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Vantive Health LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Extraneal | Periotneal Dialysis |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2006-08-25
- Last updated
- 2025-07-15
- Results posted
- 2009-06-17
Locations
11 sites across 4 countries: United States, Australia, Belgium, Canada
Source: ClinicalTrials.gov record NCT00368641. Inclusion in this directory is not an endorsement.